Invima, Colombia’s National Institute of Food and Drug Surveillance, has canceled the Mandatory Health Notifications for 136 semi-permanent nail polishes sold in the country, effectively banning them from the market. Across outlets, reports converge that the measure targets products containing two specific ingredients—Trimethylbenzoyl Diphenylphosphine Oxide (TPO) and N,N-dimethyl-p-toluidine (DMPT)—which are restricted under Andean Community (CAN) cosmetic safety regulations, and that the affected polishes will be illegal to market, distribute, or sell in Colombia as of February 2026.

Both sides emphasize that Invima’s decision is framed as a public health protection measure rooted in regional regulatory standards, not a discretionary or isolated move. Coverage agrees that the prohibited ingredients have been associated in international literature with carcinogenic potential, reproductive toxicity, and skin sensitization or allergic reactions, and that the action is part of a broader tightening of oversight on cosmetic products. There is shared acknowledgment that this step fits within Colombia’s obligations to harmonize health and safety rules with CAN guidelines and that Invima is acting as the competent authority to enforce these regional norms in the domestic cosmetics market.

Areas of disagreement

Responsibility and blame. Opposition-aligned outlets tend to portray the ban as a belated reaction, highlighting regulatory lag and suggesting that health authorities failed to prevent prolonged public exposure to risky products. Government-aligned coverage instead stresses that Invima is proactively fulfilling its mandate, presenting the measure as a timely, technical response once new evidence and CAN criteria were fully consolidated. While opposition narratives focus on what they frame as years of weak enforcement or permissiveness toward the cosmetics industry, pro-government reports emphasize due process, scientific evaluation, and adherence to established regulatory procedures.

Severity and risk framing. Opposition sources are more likely to underscore the potential carcinogenic and reproductive risks, using stronger language about how many consumers may already have been harmed and questioning whether other products remain unchecked. Government-aligned media acknowledge the same health risks but tend to moderate the tone, focusing on potential hazards rather than confirmed damage and stressing that the ban is precautionary. Whereas critical outlets may interpret the presence of these substances as evidence of systemic danger in the beauty market, pro-government coverage frames it as an isolated set of products now being safely removed.

Evaluation of government competence. Opposition coverage typically uses the ban as an entry point to question the broader capacity of Invima and the health ministry, linking the episode to longer-standing complaints about underfunding, bureaucracy, and inconsistent market inspections. Government-aligned outlets, by contrast, spotlight the publication of the official list, the regulatory alignment with CAN, and the announced enforcement timeline as proof that institutions are functioning and responsive. Critics stress what they see as chronic gaps in surveillance and consumer information, while supportive media highlight institutional continuity and regulatory modernization.

Economic and industry impact. Opposition narratives are more likely to stress the costs to small beauty salons, informal manicurists, and local distributors, arguing that poor prior guidance from regulators leaves them bearing the brunt of the policy shift. Government-aligned sources tend to frame economic implications as a necessary adjustment period, emphasizing that compliant products remain available and that industry must adapt to higher safety standards. While critical outlets may suggest that abrupt enforcement reflects poor planning and could deepen informality, pro-government coverage suggests that clear deadlines to 2026 and public lists of banned items give businesses sufficient time to transition.

In summary, opposition coverage tends to frame the ban as overdue, symptomatic of regulatory weakness, and economically disruptive for smaller actors, while government-aligned coverage tends to present it as a science-based, timely enforcement of regional standards that demonstrates institutional effectiveness and a balanced protection of both public health and markets.